Effectiveness of botulinum toxin for patients with chronic lateral epicondylitis .
Use of anatomic measurement to guide injection of botulinum toxin for the management of chronic lateral epicondylitis: a randomized controlled trial
CMAJ. 2010 May 18;182(8):768-73. Epub 2010 Apr 2648 patients with chronic refractory lateral epicondylitis, who had completed a course of physiotherapy and/or received corticosteroid injections, were randomized to receive placebo or botulinum toxin A at the distance of one-third the length of the forearm from the tip of the lateral epicondyle on the course of the posterior inter-osseus nerve. At the study end point of 16 weeks, injecting botulinum toxin was found to reduce the intensity of pain at rest and during maximum pinch.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
